Affect Therapeutics

If you are looking at Affect Therapeutics in Jacksonville, FL, the basics worth knowing up front: The facility's programming is outpatient (IOP, MAT), not residential. This page walks through the questions that tend to matter most to families weighing a specific program.

Care levels at Affect Therapeutics

On care levels specifically: Affect Therapeutics is an outpatient-focused program (IOP, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Affect Therapeutics to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

Affect Therapeutics accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Three questions to put to Affect Therapeutics before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.